About Wiliance Pharmaceuticals
Wiliance Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing, trading, and distribution services in India. Its Indian entity Wiliance Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr. Wiliance Pharmaceuticals offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Distribution, Franchise Services and Drug Manufacturing.
Company details
Wiliance Pharmaceuticals is identified as an ISO 9001-2008 and WHO GMP-certified entity that specializes in the ethical manufacturing, trading, and distribution of pharmaceutical products, including antibiotics and dietary supplements. Facilities are situated in Bhopal, with operations extending to Mumbai and Himachal Pradesh. Third-party manufacturing and Monopoly PCD Pharma Franchise opportunities are offered, enabling businesses to focus on marketing while quality products are supplied. A vision is established to deliver affordable therapeutic solutions globally, supported by a team of professionals.
- SectorsHealthcare
- Email••••••••
- Website wiliancepharmaceuticals.com
- Legal Name Wiliance Pharmaceuticals Pvt Ltd
- Date of Incorporation 17 Dec, 2013
- Jurisdiction Bhopal, Madhya Pradesh, India
- Indian entity revenue₹1.03 Cr
FY 2025 · -6% YoY
- Indian entity net loss-₹4.8 Lakh
FY 2025 · -5% margin
- Indian entity EBITDA-₹2.7 Lakh
FY 2025 · -3% margin
Associated legal entities of Wiliance Pharmaceuticals
Wiliance Pharmaceuticals operates through Wiliance Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Wiliance Pharmaceuticals Private Limited CIN U24232MP2013PTC031964 | Active | 17 Dec 2013 | Bhopal, Madhya Pradesh | ₹1.0 Cr | 3 | View details |
Products & Services of Wiliance Pharmaceuticals
Wiliance Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are produced for various medical treatments to meet therapeutic requirements.
Capsules are manufactured for delivering active ingredients in a controlled manner.
Board of directors of Wiliance Pharmaceuticals Private Limited (Wiliance Pharmaceuticals)
Wiliance Pharmaceuticals Private Limited is the primary company behind Wiliance Pharmaceuticals. The board of Wiliance Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Subhash Gautam, appointed in 2013. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subhash Gautam DIN 06746311 | Director | 17 Dec 2013 | 12 yrs 10 mo | Wiliance Pharmaceuticals Private Limited |
| Brijendra Kumar Nigam DIN 07470594 | Director | 31 Mar 2016 | 10 yrs 7 mo | Wiliance Pharmaceuticals Private Limited |
| Archana Mishra DIN 08554437 | Director | 05 Sep 2019 | 7 yrs 1 mo | Wiliance Pharmaceuticals Private Limited |
Financials of Wiliance Pharmaceuticals
Figures of Wiliance Pharmaceuticals Private Limited, the primary company behind Wiliance Pharmaceuticals, for FY 2025. Revenue was ₹1.03 Cr (-6% year on year). Net loss was -₹4.8 Lakh (-5% margin). EBITDA was -₹2.7 Lakh (-3% margin). Revenue has grown at a compounded annual rate of +11% over three years and +17% over five years.
- ₹1.03 CrRevenue · FY 2025 · -6% YoY
- -₹4.8 LakhNet loss · -5% margin
- -₹2.7 LakhEBITDA · -3% margin
- ₹5 LakhPaid-up capital
- +11%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Wiliance Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Wiliance Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Wiliance Pharmaceuticals
The primary company behind Wiliance Pharmaceuticals, Wiliance Pharmaceuticals Private Limited, reported revenue of ₹1.03 Cr for FY 2025, down 6% year on year.
Wiliance Pharmaceuticals is identified as an ISO 9001-2008 and WHO GMP-certified entity that specializes in the ethical manufacturing, trading, and distribution of pharmaceutical products, including antibiotics and dietary supplements. Facilities are situated in Bhopal, with operations extending to Mumbai and Himachal Pradesh. Third-party manufacturing and Monopoly PCD Pharma Franchise opportunities are offered, enabling businesses to focus on marketing while quality products are supplied. A vision is established to deliver affordable therapeutic solutions globally, supported by a team of professionals.
Wiliance Pharmaceuticals offers Tablets and Capsules.
Wiliance Pharmaceuticals operates through Wiliance Pharmaceuticals Private Limited.
The legal entities of Wiliance Pharmaceuticals currently have 3 directors, including Archana Mishra, Brijendra Kumar Nigam, Subhash Gautam.